Pharmavite Remdex Makes Upper Respiratory Treatment Claims, FDA Says
This article was originally published in The Tan Sheet
Executive Summary
Labeling statements for Pharmavite's Remdex with Andropan, which is highlighted in new advertising as the "smarter way to fight colds," suggest the supplement is intended to treat upper respiratory tract diseases, FDA says in a recent "courtesy" letter.
You may also be interested in...
Pharmavite, Weider Launch Respiratory, Joint Health Supplements
Pharmavite's Remdex Head & Chest Formula dietary supplement, positioned as an "effective and non-drowsy, all natural" alternative to OTC cough/cold remedies, is slated to hit food, drug and mass outlets in August.
Supplement GMP Warning Letters Make Modest Debut In 2010
Finalization of a settlement between the Federal Trade Commission and Rexall Sundown regarding unsupported cellulite treatment claims for the firm's Cellasene dietary supplement hinges upon approval of two related class action settlements pending in California and Florida, according to FTC
In Brief
Combe sells most of its OTC brands